ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

House panel investigating NIH handling of tissue specimens.

June 24, 2005

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974

Taxol Issue Prompts Questions Forom Reader

July 26, 1991